Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data

J. Cohen, K. Beernaert, L. Van den Block, L. Morin, K. Hunt, G. Miccinesi, M. Cardenas-Turanzas, B. Onwuteaka-Philipsen, R. MacLeod, M. Ruiz-Ramos, DM. Wilson, M. Loucka, A. Csikos, YJ. Rhee, J. Teno, W. Ko, L. Deliens, D. Houttekier,

. 2017 ; 27 (1) : 14. [pub] 20170303

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010771

Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8% were from lung cancer and 4.4% from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5% in South Korea to 57.1% in Mexico, while hospital deaths ranged from 27.5% in New Zealand to 77.4% in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4% in Canada to 55.4% in Mexico, while hospital deaths ranged from 41.8% in Mexico to 78.9% in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease. LUNG DISEASE: IMPROVING END-OF-LIFE CARE: Structured palliative care similar to that offered to cancer sufferers should be in place for patients with chronic lung disease. Joachim Cohen at Vrije University in Brussels and co-workers examined international death certificate data collected from 14 countries to determine place of death for patients with lung cancer and chronic obstructive pulmonary disease (COPD). While patients with COPD suffer similar symptoms to lung cancer in their final days, few COPD patients receive palliative care or achieve the common wish of dying at home. This may be partly due to the inherent unpredictability of final-stage COPD compared with lung cancer. Cohen's team found that, with the exception of Italy, Spain, and Mexico, patients with COPD were significantly more likely to die in hospital than at home. They highlight the need for improved COPD palliative care provision.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010771
003      
CZ-PrNML
005      
20180426110526.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41533-017-0017-y $2 doi
035    __
$a (PubMed)28258277
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Cohen, Joachim $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium. jcohen@vub.ac.be.
245    10
$a Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data / $c J. Cohen, K. Beernaert, L. Van den Block, L. Morin, K. Hunt, G. Miccinesi, M. Cardenas-Turanzas, B. Onwuteaka-Philipsen, R. MacLeod, M. Ruiz-Ramos, DM. Wilson, M. Loucka, A. Csikos, YJ. Rhee, J. Teno, W. Ko, L. Deliens, D. Houttekier,
520    9_
$a Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8% were from lung cancer and 4.4% from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5% in South Korea to 57.1% in Mexico, while hospital deaths ranged from 27.5% in New Zealand to 77.4% in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4% in Canada to 55.4% in Mexico, while hospital deaths ranged from 41.8% in Mexico to 78.9% in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease. LUNG DISEASE: IMPROVING END-OF-LIFE CARE: Structured palliative care similar to that offered to cancer sufferers should be in place for patients with chronic lung disease. Joachim Cohen at Vrije University in Brussels and co-workers examined international death certificate data collected from 14 countries to determine place of death for patients with lung cancer and chronic obstructive pulmonary disease (COPD). While patients with COPD suffer similar symptoms to lung cancer in their final days, few COPD patients receive palliative care or achieve the common wish of dying at home. This may be partly due to the inherent unpredictability of final-stage COPD compared with lung cancer. Cohen's team found that, with the exception of Italy, Spain, and Mexico, patients with COPD were significantly more likely to die in hospital than at home. They highlight the need for improved COPD palliative care provision.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a smrt $7 D003643
650    _2
$a úmrtní listy $7 D003644
650    _2
$a Evropa $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a služby domácí péče $x statistika a číselné údaje $7 D006699
650    12
$a hospice $7 D006738
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    12
$a nemocnice $7 D006761
650    _2
$a lidé $7 D006801
650    _2
$a logistické modely $7 D016015
650    12
$a nádory plic $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a manželský stav $7 D017533
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a Nový Zéland $7 D009520
650    _2
$a Severní Amerika $7 D009656
650    _2
$a paliativní péče $7 D010166
650    12
$a chronická obstrukční plicní nemoc $7 D029424
650    _2
$a Korejská republika $7 D056910
650    _2
$a péče o umírající $x statistika a číselné údaje $7 D013727
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Beernaert, Kim $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium.
700    1_
$a Van den Block, Lieve $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium. Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
700    1_
$a Morin, Lucas $u National Observatory of End of Life Care, Paris, France. Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
700    1_
$a Hunt, Katherine $u University of Southampton, Health Sciences, Southampton, UK.
700    1_
$a Miccinesi, Guido $u Cancer Prevention and Research Institute, ISPO, Clinical and Descriptive Epidemiology Unit, Florence, Italy.
700    1_
$a Cardenas-Turanzas, Marylou $u The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Onwuteaka-Philipsen, Bregje $u EMGO Institute for Health and Care Research, Public and Occupational Health, and Palliative Care Expertise Centre, VU Medical Centre, Amsterdam, The Netherlands.
700    1_
$a MacLeod, Rod $u Hammond Care and University of Sydney, Sydney, Australia.
700    1_
$a Ruiz-Ramos, Miguel $u Ministry of Health, Government of Andalusia, Seville, Spain.
700    1_
$a Wilson, Donna M $u Faculty of Nursing, University of Alberta, Edmonton, AB, Canada.
700    1_
$a Loucka, Martin $u Center for Palliative Care, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Csikos, Agnes $u University of Pécs Medical School, Pécs, Hungary.
700    1_
$a Rhee, Yong-Joo $u Dongduk Women's University, Health Sciences, Seoul, Republic of Korea.
700    1_
$a Teno, Joan $u University of Washington, Cambia Palliative Care Center of Excellence, Division of Gerontology and Geriatrics, Seatle, WA, USA.
700    1_
$a Ko, Winne $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium.
700    1_
$a Deliens, Luc $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium. Department of Medical Oncology, Ghent University, Ghent, Belgium.
700    1_
$a Houttekier, Dirk $u Vrije Universiteit Brussel (VUB) and Ghent University, End-of-Life Care Research Group, Brussels, Belgium.
773    0_
$w MED00195024 $t NPJ primary care respiratory medicine $x 2055-1010 $g Roč. 27, č. 1 (2017), s. 14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28258277 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180426110637 $b ABA008
999    __
$a ok $b bmc $g 1288256 $s 1007583
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 27 $c 1 $d 14 $e 20170303 $i 2055-1010 $m NPJ primary care respiratory medicine $n NPJ Prim Care Respir Med $x MED00195024
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options